BAMF Health

02/04/2026

Meet the FMAB Founding Board! All month long, we're introducing you to the founding members working to further the mission of our Foundation for Medical Advancement and Breakthroughs.

Denise Christy, Chief Commercial Officer at ArtiMed, brings decades of experience in healthcare and philanthropy.

Dr. Lowell Fernander, Chief Medical Officer at Rocket, brings deep expertise in clinical care, population health, and organizational leadership.

Join us in welcoming them!

02/04/2026

Every patient deserves access to Theranostics, no matter where they live. That's why we keep pushing!

In 2026, we treated patients from 26 states and 2 countries outside the U.S.: Italy and Canada.

Advanced scans, innovative treatments, and a superior patient experience are worth traveling for.

01/30/2026

1 - 2 - 3 - BAMF! 🫵🏼

Today, we officially kicked off 2026 as ONE BAMF team. This EXTRAORDINARY group has already done what no one thought possible. Now, watch us do it again!

01/29/2026

As awareness of Theranostics grows, more facilities will emerge offering services. But it's important to know what to look for and ask for.

🔸 Can you get seen quickly?
🔸 Does it have advanced imaging technology?
🔸 Is the facility built for Theranostics?
🔸 Do you have access to a SPECT/CT scan after treatment?
🔸 What is the patient experience like?

Learn what else to look for: https://www.bamfhealth.com/news/what-to-look-for-in-a-theranostics-center/

01/28/2026

“I remember lying in the German hospital thinking: I have the means to get to Germany, but so many people don’t. Here we live in what should be the greatest country on earth, yet patients had to leave the country to get this treatment.” – Doug Meijer.

When Doug traveled to Germany in 2017 for a groundbreaking Theranostics treatment from Dr. Harshad Kulkarni, few could have imagined what would follow. Accompanied by Anthony Chang, that journey sparked a shared vision, one that ultimately led Anthony to bring Theranostics—and Dr. Kulkarni—to the U.S.

Doug and Dr. Brandon Mancini dig deeper into BAMF's story on Keith Shaw's Today in Tech podcast:

This episode of Today in Tech is different.Instead of talking about enterprise software or cybersecurity, we step inside one man’s fight for survival — and t...

01/27/2026

To John, family means everything. Life revolves around his children, grandchildren, great-grandchildren, and his partner, Mary.

After battling prostate cancer in the early 2000s, he thought he was in the clear. But when his PSA started rising again, his oncologist referred him to BAMF, where he learned about an opportunity to be the first patient in the world to participate in a new radioligand therapy trial.

This trial, sponsored by ARTBIO, has the potential to reshape the treatment landscape for advanced prostate cancer.

Read more of John’s story and learn about the trial: https://www.bamfhealth.com/news/world-traveler-becomes-first-in-world-patient/

01/22/2026

NEW JOB ALERT in our Radiopharmacy!

We're looking for a Radiopharmacy Support Tech and a Radiopharmacy Operations Specialist to join our team.

Learn more and apply: https://bamfhealth.wd5.myworkdayjobs.com/External

01/20/2026

“I gotta tell you, I kind of like the idea of being first!” First person in the world, to be exact!

Bill was the first patient dosed in a groundbreaking clinical trial at BAMF Health. The trial explores a PSMA-targeting agent that could address current limitations of available radiopharmaceutical therapies for patients with prostate cancer.

We admire Bill’s passion for research and giving back and are hopeful his contributions will lead to more options for patients just like him.

01/20/2026

“I gotta tell you, I kind of like the idea of being first!” First person in the world, to be exact! Bill was the first patient dosed in a groundbreaking clinical trial at BAMF Health.

The trial, sponsored by Archeus Technologies and the University of Wisconsin Alumni Research Foundation (WARF), explores a PSMA-targeting agent that could address current limitations of available radiopharmaceutical therapies for patients with prostate cancer.

We admire Bill’s passion for research and giving back and are hopeful his contributions will lead to more options for patients just like him.

Bill was the first patient dosed in a groundbreaking clinical trial at BAMF Health. The trial, sponsored by Archeus Technologies and the University of Wiscon...

01/16/2026

Confused about Theranostics? Let us simplify it for you!

Theranostics is a type of precision medicine. It uses radiopharmaceuticals to precisely find and treat diseases at the molecular level.

We use molecular imaging to determine if a target on diseased cells is present, then use molecular (radiopharmaceutical) therapy to treat it.

We see what we treat, then treat what we see. That's Theranostics!

01/15/2026

Our clinical trial options for cancer are rapidly expanding. We now have multiple imaging and therapy options for patients with:

🔸Breast cancer
🔸Non-small cell lung cancer
🔸Colorectal cancer
🔸Gynecological cancers (cervical, ovarian, endometrial)
🔸Gastrointestinal cancers
🔸Prostate cancer

See all of our available clinical trials: https://hubs.la/Q03-Nbtj0

01/14/2026

We join many in celebrating the milestone achievement: 7 in 10 people in the U.S. survive cancer for five years or more.

Thanks to increased and better screening and advancements in treatment options, we're finding cancer earlier and managing it over a longer period of time.

But there's more to be done. We won't quit until 100% of people survive—or cancer is eradicated altogether.

See the latest data from the American Cancer Society: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2026-cancer-facts-figures.html